DA32 Life Science Tech Acquisition announced that its board has determined to redeem all of outstanding shares of Class A stock effective July 28. The company will not complete a business combination by deadline.
The per-share redemption price will be approximately $10.31, according to a press release.
The SPAC raised $200 million two years ago this week. Read more.
